Nigeria Pharmaceutical Packaging Market Size & Outlook, 2025-2033
Nigeria Pharmaceutical Packaging Market Insights
- Packaging Market Insights analysis indicates that the Nigeria Pharmaceutical Packaging Market size, valued at USD 0.68 Billion in 2024, is expected to expand to USD 1.42 Billion by 2033.
- The Nigeria market is forecasted to expand at a CAGR of 8.48% spanning 2026–2033.
- Tertiary held the leading position among By Product segments in 2024, based on market size.
- Tertiary is projected to post the fastest growth rate, sustaining its position as the most attractive By Product segment during the forecast horizon.
Source: PIAnalysis Company Publications, Primary Interviews.
Other Key Findings
- In 2024, Nigeria represented 0.43% of the overall global Pharmaceutical Packaging Market size.
- United States is projected to lead the global Pharmaceutical Packaging Market size by 2033.
- Across Middle East and Africa, United Arab Emirates is anticipated to hold the dominant position in market size by 2033.
- Saudi Arabia is forecasted to expand at the fastest pace in Middle East and Africa, attaining USD 5.16 Billion by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 0.68 Billion |
| Market Size In 2033 | USD 1.42 Billion |
| Largest segment | Tertiary |
| Units | Revenue in USD Billion |
| CAGR | 8.48% (2025-2033) |
| Segmnetation Covered | |
| By Product |
|
| By Material |
|
| By Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Nigeria Pharmaceutical Packaging Market By Product 2025-2033 (USD Billion)
| By Product | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tertiary | XX.x | XX.x | XX.x | 0.36 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Secondary | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Primary | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
Nigeria Pharmaceutical Packaging Market By Material 2025-2033 (USD Billion)
| By Material | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paper & Paperboard | XX.x | XX.x | XX.x | 0.29 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Plastics & Polymers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Glass | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Aluminum Foil | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
Nigeria Pharmaceutical Packaging Market By Application 2025-2033 (USD Billion)
| By Application | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail Pharmacy | XX.x | XX.x | XX.x | 0.24 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pharmaceutical Manufacturing | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Institutional Pharmacy | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Contract Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.